Posted inHEALTH WORLD NEWS
Swissmedic approves Novartis’ malaria medicine for babies
The treatment was developed in collaboration with Medicines for Malaria Venture. The Swiss Agency for Therapeutic Products (Swissmedic) has approved Novartis’ Coartem (artemether-lumefantrine) Baby, described as the first malaria medicine…



